Evidence map›Paper›PMID 29311665›Full record

ReviewMolecular psychiatry2018

Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.

J A Lieberman, R R Girgis, G Brucato, H Moore, F Provenzano, L Kegeles, D Javitt, J Kantrowitz, M M Wall, C M Corcoran and 2 more

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 216 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
216citing papers in PubMed, 2 pooled it
23.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

216 citing papers in PubMed, 2 syntheses or guidelines pooled it, 389 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  5. Modulation of hippocampal activity in schizophrenia with levetiracetam: a randomized, double-blind, cross-over, placebo-controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Putative glymphatic function and free water in schizophrenia: A 7T DTI study across psychosis stages.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

156 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

J A LiebermanDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA. JLieberman@columbia.edu.
R R GirgisDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
G BrucatoDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
H MooreDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
F ProvenzanoDepartment of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
L KegelesDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
D JavittDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
J KantrowitzDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
M M WallDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
C M CorcoranDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
S A SchobelDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
S A SmallDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA. sas68@cumc.columbia.edu.
Columbia University · USNew York State Psychiatric InstituteNew York Psychoanalytic Society and Institute · US

Funding

Thought disorder and social cognition in clinical risk states for schizophreniaR01MH107558 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI CORCORAN, CHERYL MARY · 2016 to 2020
$3.3M
Longitudinal Imaging of Patients at Clinical Risk for Psychosis.R01MH093398 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SMALL, SCOTT A · 2011 to 2015
$2.5M
Olfaction in the Psychosis Prodrome: Behavioral and ERP MeasuresR21MH086125 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI BRUDER, GERARD E, CORCORAN, CHERYL MARY · 2009 to 2010
$440k
Multimodal MR Imaging of the Glutamate System in SchizophreniaK23MH106746 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI GIRGIS, RAGY RAMSIS · 2015 to 2016
$370k
NIMH NIH HHS K23 MH106746NIMH NIH HHS R01 MH093398NIMH NIH HHS R01 MH107558NIMH NIH HHS R21 MH086125
6 · The paper itself

Abstract

Scientists have long sought to characterize the pathophysiologic basis of schizophrenia and develop biomarkers that could identify the illness. Extensive postmortem and in vivo neuroimaging research has described the early involvement of the hippocampus in the pathophysiology of schizophrenia. In this context, we have developed a hypothesis that describes the evolution of schizophrenia-from the premorbid through the prodromal stages to syndromal psychosis-and posits dysregulation of glutamate neurotransmission beginning in the CA1 region of the hippocampus as inducing attenuated psychotic symptoms and initiating the transition to syndromal psychosis. As the illness progresses, this pathological process expands to other regions of the hippocampal circuit and projection fields in other anatomic areas including the frontal cortex, and induces an atrophic process in which hippocampal neuropil is reduced and interneurons are lost. This paper will describe the studies of our group and other investigators supporting this pathophysiological hypothesis, as well as its implications for early detection and therapeutic intervention.

Indexed as

AnimalsHippocampusHumansModels, NeurologicalSchizophrenia

Identifiers

PMID29311665
PMCPMC6037569
OpenAlexW2783894827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.